REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 27 filers reported holding REDHILL BIOPHARMA LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $408,000 | +83.8% | 37,750 | +46.6% | 0.28% | +82.4% |
Q2 2017 | $222,000 | +36.2% | 25,750 | +51.5% | 0.15% | +36.6% |
Q1 2017 | $163,000 | -28.8% | 17,000 | +3.0% | 0.11% | -13.2% |
Q3 2016 | $229,000 | +27.9% | 16,500 | 0.0% | 0.13% | +27.7% |
Q2 2016 | $179,000 | -11.4% | 16,500 | 0.0% | 0.10% | -22.9% |
Q1 2016 | $202,000 | +8.0% | 16,500 | +13.8% | 0.13% | +35.1% |
Q4 2015 | $187,000 | -34.2% | 14,500 | -34.1% | 0.10% | -22.4% |
Q3 2015 | $284,000 | – | 22,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 717,203 | $9,962,000 | 0.89% |
BANK HAPOALIM BM | 147,504 | $2,049,000 | 0.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 246,000 | $3,417,000 | 0.19% |
Family Management Corp | 16,500 | $229,000 | 0.13% |
Orbimed Advisors | 564,900 | $7,846,000 | 0.09% |
SABBY MANAGEMENT, LLC | 63,800 | $888,000 | 0.03% |
INGALLS & SNYDER LLC | 41,550 | $577,000 | 0.03% |
Candriam S.C.A. | 71,267 | $992,000 | 0.02% |
MONETARY MANAGEMENT GROUP INC | 3,000 | $42,000 | 0.02% |
D.A. DAVIDSON & CO. | 26,500 | $368,000 | 0.01% |